<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04570007</url>
  </required_header>
  <id_info>
    <org_study_id>2/2020</org_study_id>
    <nct_id>NCT04570007</nct_id>
  </id_info>
  <brief_title>Vitreous Fragments Length After Pars Plana Vitrectomy</brief_title>
  <official_title>Vitreous Fragments Length After Pars Plana Vitrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Policlinico San Martino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Policlinico San Martino</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To measure vitreous collagen fragments length after pars plana vitrectomy performed at&#xD;
      different cut rates&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pars plana vitrectomy consists in the removal of vitreous obtained with a vitreous cutter.&#xD;
      The instruments attracts vitreous in its port through active suction and cuts with a blade at&#xD;
      different cut rates. There is no consensus as to which cut rate would be ideal in order to&#xD;
      minimize traction, neither there is agreement on whether increasing cut rates generate&#xD;
      shorter collagen fragments or the fluid turbulence creates unpredictable flows at the port&#xD;
      generating fragments of different length.&#xD;
&#xD;
      The investigators plan to gather vitreous cut at 1,000, 2,000, 4,000, 8,000 and 16,000 cuts&#xD;
      per minute and measure vitreous collagen average length&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2020</start_date>
  <completion_date type="Anticipated">December 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>collagen fragment molecular weigth</measure>
    <time_frame>at time of surgery</time_frame>
    <description>collagen passed through the vitreous cutter is examined with regard to collagen moecular weigth</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Vitreous Disorder</condition>
  <condition>Vitreous Anomalies</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pars Plana Vitrectomy</intervention_name>
    <description>removal of vitreous with vitreous cutter</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      vitreous collagen&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients over 18 undergoing pars plana vitrectomy for macular surgery or retinal detachment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient undergoing pars plana vitrectomy for:&#xD;
&#xD;
          -  macular pucker&#xD;
&#xD;
          -  macular hole-&#xD;
&#xD;
          -  retinal detachment&#xD;
&#xD;
          -  age &gt;18&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unwilling to participate&#xD;
&#xD;
          -  previous trauma&#xD;
&#xD;
          -  vitreous haemorrhage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Tommaso Rossi</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Policlinico San MArtino</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tommaso Rossi</last_name>
    <phone>+393482645034</phone>
    <email>tommaso.rossi024@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Policlinico San Martino</name>
      <address>
        <city>Genova</city>
        <state>RM</state>
        <zip>16100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso Rossi</last_name>
      <phone>3482645034</phone>
      <email>tommaso.rossi024@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 24, 2020</study_first_submitted>
  <study_first_submitted_qc>September 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

